IP Library Granted Patent US 10,519,514
Granted Patent B2
US 10,519,514 · App. 15/511,893 · Granted Dec 31, 2019

Detection method for

Inventors: Danny Filer (Bristol, GB); Claire Ferrao (Trowbridge, GB); Sharon Chadwick (Trowbridge, GB)
Assignee: Atlas Genetics Limited
C12Q1/689C12Q2600/158C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,519,514
App. No.
15/511,893
Granted
Dec 31, 2019
Kind
B2
Abstract

A method of detecting the presence of Neisseria gonorrhoeae in a sample. The method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The method may involve a step of amplifying the target sequence, and may involve hybridising the target sequence to a nucleic acid probe and identifying hybridisation. The method may involve simultaneous detection of other target sequences, e.g. from other pathogens.

Claims (5)

1. A method of detecting the presence of Neisseria gonorrhoeae in a sample comprising:

amplifying a first target sequence comprising SEQ ID NO: 1 and a second target sequence comprising SEQ ID NO: 6;

hybridising the first target sequence to a nucleic acid probe comprising SEQ ID NO: 3 and a ferrocene label;

hybridising the second target sequence to a nucleic acid probe comprising SEQ ID NO: 8 and a ferrocene label; and

identifying the occurrence of hybridisation by detecting the state of the labelled probes, wherein said step of amplifying the first target sequence and the second target sequence uses the polymerase chain reaction and involves the use of forward primers consisting of SEQ ID NOs: 4 and 9 and reverse primers consisting of SEQ ID NOs: 5 and 10.

Assignments (6)
SECURITY INTEREST Recorded Mar 25, 2025
From: BINX HEALTH LIMITED
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 070620/0287 →
RELEASE OF SECURITY INTEREST Recorded Jan 18, 2025
From: BX HEP AGGREGATOR, LLC,
To: BINX HEALTH LIMITED
Reel/Frame 069925/0466 →
ASSIGNMENT OF PATENT SECURITY AGREEMENT Recorded Oct 3, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: BX HEP AGGREGATOR, LLC
Reel/Frame 069107/0116 →
PATENT SECURITY AGREEMENT Recorded Apr 7, 2021
From: BINX HEALTH LIMITED
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 055859/0724 →
CHANGE OF NAME Recorded Dec 12, 2019
From: ATLAS GENETICS LIMITED
To: BINX HEALTH LIMITED
Reel/Frame 051264/0447 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2017
From: FERRAO, CLAIRE; FILER, DANNY; CHADWICK, SHARON
To: ATLAS GENETICS LIMITED
Reel/Frame 043296/0956 →
Priority Claims (1)
GB 1416459.4 · Sep 17, 2014 · national
Continuity (1)
Related Publication 20170260572A1 · Sep 14, 2017